Valens Semiconductor Ltd. filings document the company’s foreign-issuer current reports, semiconductor connectivity business, governance matters and capital-structure disclosures. Form 6-K reports furnish earnings releases, product announcements involving VA7000 A-PHY chipsets and automotive camera applications, annual meeting voting results, management-transition disclosure, and exhibits incorporated by reference into Form F-3 and Form S-8 registration statements.
The filing record also covers operating and financial results, material-event disclosures, risk factors and corporate governance under the company’s public-company reporting framework. These documents relate to Valens’ audio-video and automotive connectivity markets, including high-speed video and data transmission technologies tied to HDBaseT and MIPI A-PHY.
Dror Jerushalmi reported sales of Ordinary shares under the Employee Stock Option Plan. The Form 144 lists three sales: 12/05/2025 of 42,631 shares for $72,760.69, 01/02/2026 of 254,131 shares for $463,648.70, and 02/02/2026 of 199,758 shares for $308,719.22. The transactions are described as cash upon exercise and identify Oppenheimer & Co. Inc. as the broker.
VLN filed a notice of proposed sale of 16,250 ordinary shares under an Employee Stock Option Plan, dated 02/25/2026, to be exercised for cash upon exercise.
The filing also discloses recent sales by Dror Jerushalmi: 12/05/2025 42,631 shares for $72,760.69, 01/02/2026 254,131 shares for $463,648.70, and 02/02/2026 183,508 shares for $283,531.72.
VLN insider reported proposed and recent sales of ordinary shares under an Employee Stock Option Plan. The filing lists proposed securities to be sold from the plan and three completed sales reported in the past three months: 12/05/2025 — 42,631 shares for $72,760.69; 01/02/2026 — 254,131 shares for $463,648.70; 02/02/2026 — 168,107 shares for $260,122.20.
The securities to be sold are listed as arising from an Employee Stock Option Plan with cash upon exercise noted as the method. The filing supplies holder and address details for the reporting person.
Valens Semiconductor Ltd. reported continued growth for Q4 and full year 2025, with quarterly revenue of $19.4M and full-year revenue of $70.6M, up from $57.9M in 2024, a 22% increase. Full-year gross margin improved to 62.4%.
The company remained loss-making but narrowed its net loss to $31.6M from $36.6M, while Adjusted EBITDA loss improved to $16.9M from $21.1M. Cash, cash equivalents and short-term deposits totaled $92.6M as of December 31, 2025. Management launched an operational efficiency plan expected to reduce annual operating expenses by about $5M and guided 2026 revenue to $75.0M–$77.0M (around 8% growth at the midpoint), with Q1 2026 revenue projected at $16.3M–$16.7M and a continued Adjusted EBITDA loss.
Valens Semiconductor filed its 2025 annual report outlining a cyclical semiconductor business exposed to global macro, supply-chain and pricing pressures. The company generated most 2025 revenue from cross-industry products, with automotive also significant, and about 15% of revenue coming from China, which is sensitive to evolving U.S. export controls.
Customer concentration remained high, as roughly 31% of 2025 revenue came from the top three customers, all buying through short‑term orders. The filing describes a 2024 quality incident that led to $2.2 million of expenses, followed by a partial reversal and an expected insurance recovery, as well as ongoing warranty and product liability risks.
Valens highlights competition, rapid technology change, and the need for continuous R&D, including after its 2024 acquisition of Acroname. It also notes a CEO transition in late 2025 and an efficiency plan announced in early 2026 that reduced the workforce by about 10%. Additional sections discuss exposure to currency volatility, cyber and AI-related risks, talent retention challenges and heavy reliance on third‑party manufacturing.
Dror Jerushalmi reported sales of ordinary shares under Rule 144. The filing lists three dispositions: 42,631 shares on 12/05/2025 for $72,760.69, 254,131 shares on 01/02/2026 for $463,648.70, and 167,008 shares on 02/02/2026 for $258,451.72. The excerpt also shows 106,342,415 ordinary shares as of 02/23/2026 as a context figure.
VLN reported a Form 144 notice for proposed sales of ordinary shares by a holder and disclosed recent completed sales. The notice lists 16,250 shares to be sold under an Employee Stock Option Plan, and records three sales by Dror Jerushalmi: 12/05/2025 for 42,631 shares ($72,760.69), 01/02/2026 for 254,131 shares ($463,648.70), and 02/02/2026 for 150,758 shares ($233,264.22).
VLN insider sales reported via Form 144. The filing lists sales by Dror Jerushalmi: 12/05/2025 — 42,631 Ordinary shares for $72,760.69; 01/02/2026 — 254,131 Ordinary shares for $463,648.70; 02/02/2026 — 140,708 Ordinary shares for $218,189.22.
The reported transactions show cash proceeds upon exercise of options under an Employee Stock Option Plan and list Oppenheimer & Co. Inc. as broker. The filing documents routine insider dispositions rather than corporate actions.
Valens Semiconductor and MCNEX are jointly launching a new family of high-resolution automotive front and rear cameras that use Valens’ VA7000 chipsets to transmit QHD (2560×1440) video over unshielded twisted pair and low-cost coaxial cables.
The cameras are designed for ADAS and autonomous driving, helping carmakers cut wiring harness cost and complexity while maintaining image quality. MCNEX is also introducing a 4K, 60fps rear-view camera based on the same A-PHY technology, with the first OEM vehicle production based on these chipsets expected to start in early 2027.
A shareholder of Valens Semiconductor (symbol VLN) filed a Rule 144 notice to sell 6,300 ordinary shares through Oppenheimer & Co. Inc. on the NYSE, with an aggregate market value of $9,702.00. The filing shows 106,342,415 ordinary shares outstanding.
The shares to be sold were acquired on 06/01/2017 through an Employee Stock Option Plan, with cash payment upon exercise dated 02/12/2026. The person for whose account the sale is made represents that they do not know of any undisclosed material adverse information about the issuer.
The form also lists sales during the past three months by Dror Jerushalmi, including 42,631 ordinary shares sold on 12/05/2025 for $72,760.69, 254,131 shares on 01/02/2026 for $463,648.70, and 134,408 shares on 02/02/2026 for $208,332.40.